Methods for creating integration-free, virus-free, exogenous oncogene-free ips cells and compositions for use in such methods
AssigneeCellular Engineering Technologies, Inc.
InventorsAlan B. MOY, Anant KAMATH
Life of this patent
Estimating the term…
Loading patent…
AssigneeCellular Engineering Technologies, Inc.
InventorsAlan B. MOY, Anant KAMATH
Estimating the term…
Methods are disclosed for reprogramming a somatic cell, including an adherent cell and a cell in suspension, into an induced pluripotent stem comprising expressing exogenous Sox-2, exogenous Klf-4, exogenous Oct3/4 from DNA that has not integrated into the genome of the somatic cell, suppressing p53 activity within the somatic cell, and exposing the somatic cell to reprogramming-assistance factors comprising an exogenous Alk-5 inhibitor, an exogenous histone deacetylase inhibitor, and an exogenous activator of glycolysis. Compositions and kits for use in such methods are also disclosed as are cells made by such a method.
A method for reprogramming a somatic cell comprising:
A composition comprising a somatic cell and a cell culture medium, the somatic cell comprising episomal polynucleotides encoding Sox-2, Klf-4, and Oct3/4, and the medium comprising an exogenous Alk-5 inhibitor, an exogenous histone deacetylase inhibitor, an exogenous activator of glycolysis, and exogenous ascorbic acid.
A kit comprising:
Dependencies are inferred from the claim text.